<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0005">
 <label>Table 1</label>
 <caption>
  <p>Summary of 3 cases series examining the use of convalescent plasma in the setting of SARS-CoV-2.</p>
 </caption>
 <alt-text id="al0005">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Study (year)</th>
    <th>Number of patients (age range in years)</th>
    <th>Patient characteristics</th>
    <th>Volume of CP transfused (average day from admission)</th>
    <th>CP antibody profile</th>
    <th>Summary of outcomes observed post-transfusion (ratio of patients demonstrating outcome)</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Shen et al [
     <xref rid="bb0225" ref-type="bibr">45</xref>] (2020)
    </td>
    <td>5 (36-73)</td>
    <td>- qRT-PCR confirmed COVID-19 infection
     <break/>- severe PNA
     <break/>- Pao
     <sub>2</sub>/Fio
     <sub>2</sub> &lt;300 mmHG
     <break/>- mechanically ventilated
    </td>
    <td>400 mL (18.2)</td>
    <td>SARS-CoV-2–specific antibody titer &gt; 1:1000 neutralizing antibody titer &gt; 1: 40</td>
    <td>-Increase in Pao
     <sub>2</sub>/Fio
     <sub>2</sub> within 12 days
     <break/>-Decrease in viral loads within 12 days
     <break/>-Increase in SARS-CoV-2–specific and
     <break/> neutralizing antibody titers
     <break/>-Resolution of ARDS within 12 days
     <break/> (4/5)
     <break/>- Mechanical ventilation weaned within
     <break/> 14 days (3/5)
     <break/>-Discharged between days 51-55 (3/5)
     <break/>-Remained mechanically ventilated (2/5)
    </td>
   </tr>
   <tr>
    <td>Duan et al [
     <xref rid="bb0230" ref-type="bibr">46</xref>] (2020)
    </td>
    <td>10 (34 -78)</td>
    <td>- qRT-PCR confirmed COVID-19 infection
     <break/>- 2/4 of the following:
     <break/>1) ≥18 years
     <break/>2) respiratory distress
     <break/>3) O
     <sub>2</sub> saturation &lt;93% at rest
     <break/>4) Pao
     <sub>2</sub>/Fio
     <sub>2</sub> &lt;300 mmHg
    </td>
    <td>200 mL (16.5)</td>
    <td>Neutralization antibody titer &gt;1:640</td>
    <td>-Clinical symptoms were significantly within 3 days
     <break/>-Increase in O
     <sub>2</sub> saturation within 3 days
     <break/>-Trend in increased lymphocyte counts
     <break/>-Trend in decreased C-reactive protein
     <break/>-Imaging showed varying degrees of
     <break/> absorption of lung lesions within 7
     <break/> days
     <break/>-Undetectable viral load (7/10)
    </td>
   </tr>
   <tr>
    <td>Zhang et al [
     <xref rid="bb0235" ref-type="bibr">47</xref>] (2020)
    </td>
    <td>4 (31-73)</td>
    <td>- Confirmed COVID-19 infection (3/4 RT-PCR positive)
     <break/>- Respiratory failure requiring mechanical ventilation (2 required ECMO)
    </td>
    <td>200-2400 mL (15.25)</td>
    <td>Not measured</td>
    <td>-Negative qRT-PCR
     <break/>-Imaging showed absorption, or partial
     <break/> absorption, of lung lesions
     <break/>-Discharged between days 18-43(3/4)
     <break/>-Remained hospitalized with multiorgan failure (1/4)
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
